Invisalign maker Align Technology (ALGN) crushed fourth-quarter expectations late Wednesday, leading ALGN stock to retake its 200-day moving average.

X

During the December quarter, sales for the clear teeth-straightening device maker climbed roughly 6% to $956.7 million, beating forecasts for $933.7 million, according to FactSet. Adjusted profit came in at $2.42 per share, up 13% and above projections for $2.18.

Align expects total 2024 sales to advance by a mid-single-digit percentage. Analysts following ALGN stock estimated $4.02 billion in sales, up 4%.

In after-hours trading on the stock market today, ALGN stock jumped more than 10% to 294.40. Shares climbed above their 200-day line for the first time since December, according to MarketSmith.com.

Follow Allison Gatlin on X, the platform formerly known as Twitter, at @IBD_AGatlin.

YOU MAY ALSO LIKE:

Pfizer Reports Surprise Profit Despite Continued Covid Sales Downfall

Vertex’s Alternative To Opioids Is ‘Not A Game-Changer,’ Says Analyst

Watch IBD’s Investing Strategies Show For Actionable Market Insights

See Stocks On The List Of Leaders Near A Buy Point

IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks